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Abstract
The lineage relationship of dendritic cells (DC) with other hematopoietic cell types has been
studied extensively, resulting in the identi®cation of different bone marrow (BM) progenitors that
give rise to distinct DC types. However, the identity of the different maturation stages of DC
precursors in the BM remains unclear. In this study we de®ne the in vivo developmental steps of
the myeloid DC lineage in mouse BM. To this end, BM cells were separated according to their
expression of CD31 (ER-MP12), Ly-6C (ER-MP20) and ER-MP58 antigens, and stimulated to develop
into myeloid DC, using granulocyte macrophage colony stimulating factor as a speci®c growth
factor. DC developed from three BM subpopulations: ER-MP12hi/20± (early blast cells), ER-MP12+/
20+ (myeloid blasts) and ER-MP12±/20hi (monocytes). The kinetic and phenotypic features of DC
developing in vitro indicate that the three populations represent successive maturation stages of
myeloid DC precursors. Within the earliest ER-MP12hi/20± population, DC precursors exclusively
occurred in the myeloid-restricted ER-MP58hi subset. By using switch cultures, we show that these
BM precursor subpopulations, when stimulated to develop into macrophages using macrophage
colony stimulating factor, retain the ability to develop into myeloid DC until advanced stages of
maturation. Together, these ®ndings support a common ER-MP12/20-de®ned differentiation
pathway for both macrophages and myeloid DC throughout their BM development.
Introduction
Dendritic cells (DC) are bone marrow (BM)-derived cells that
have the unique capacity to initiate a primary immune
response by ef®cient antigen presentation to naive T cells.
The DC system is widely distributed throughout the body, and
comprises Langerhans cells in epithelial locations, veiled cells
in lymph, interdigitating cells in lymphoid organs and inter-
stitial DC in connective tissue of non-lymphoid organs (1).
Many studies in the past few years have addressed the
lineage relationships of DC with other hematopoietic lineages.
Mainly, DC of two possible origins, lymphoid and myeloid,
have been identi®ed in human and mouse. Both types have
been shown to originate from the BM from which they can be
derived in vitro by stimulation with different growth factors (2±
4). Myeloid DC have been generated in vitro from early
common myeloid progenitors in BM and from monocytes in
peripheral blood using granulocyte macrophage colony
stimulating factor (GM-CSF) as a growth stimulus. In contrast,
using Flt-3 ligand (Flt-3L), both myeloid and lymphoid DC can
be generated in vitro from BM (5±7). A progenitor population
for human lymphoid DC, which also can give rise to lymphoid
cells, has been identi®ed in BM and thymus (3). However, data
about this DC lineage in the mouse are inconclusive since the
identity of the mature lymphoid DC has been unclear. An
earlier study on mouse thymic DC precursors has suggested
CD8a as a marker of the lymphoid-related DC lineage (8).
More recent reports, however, show that CD8a is not a reliable
marker for lymphoid DC since it can be expressed also on
myeloid DC (9) and that CD8a+ DC can be derived from
myeloid progenitors (10). A new candidate for the lymphoid-
related DC in the mouse has been proposed (11±13) which
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shows characteristics equivalent to those of human plasma-
cytoid DC (PDC).
The developmental plasticity inherent to the DC system has
been demonstrated in different studies, showing that both
common lymphoid and common myeloid progenitors are able
to differentiate into different types of DC (14±16). The studies
by Manz et al. and Mebius et al. indicated that both types of
progenitors give rise to both CD8a+ and CD8a± DC in vitro and
in vivo (14,15), while Izon et al. showed a previously
unrecognized link between early B cell and DC ontogeny
(16). Furthermore, recent experimental evidence suggests the
existence of a common DC precursor in the BM (17) as well as
in the peripheral blood (18) for CD8a+, CD8a± and presumed
PDC.
The studies cited above were mainly directed to de®ne the
origins of the different DC types and to identify their precursors
in the BM. However, the identi®cation of the different devel-
opmental stages of DC precursors in the BM still remains
unclear. In this study, we have investigated in mouse BM the
in vivo differentiation pathway of myeloid DC progenitors
identi®ed by differential ER-MP12/CD31 and ER-MP20/Ly-6C
expression. In addition, we addressed the developmental
relationship of myeloid DC precursors with macrophage
precursors.
Methods
Mice
Female C57BL6/J and C57BL6/Ly-5.1-Pep3b mice between 11
and 13 weeks of age were used in this study. Female C3HeB/
Fej mice were used as a source of allogeneic responder T
cells. Animals were speci®c pathogen free, and kept with free
access to food and water in the animal care facility at the
Erasmus University Rotterdam under the institutional guide-
lines for usage of experimental animals.
mAb and conjugates
mAb used for cell sorting, ¯ow cytometric analysis, immuno-
cytochemistry and read out of T cell activation in the mixed
leukocyte reaction (MLR) were either generated in our
laboratory or obtained from BD PharMingen (Alphen aan de
Rijn, The Netherlands). These were: biotinylated ER-MP12
(anti-CD31); FITC±ER-MP20 (anti-Ly6C); undiluted hybridoma
culture supernatants ER-MP58 (19,20), ER-MP21 (anti-CD71/
transferrin R) and M5/114 (anti-MHC class II), obtained in our
laboratory; and 53-6.7±FITC (anti-CD8a), RM4-5±PE (anti-
CD4) and HL3±phycoerythrin (PE) (anti-CD11c) purchased
from BD PharMingen. Biotinylated ER-TR3 (anti-MHC class II)
antibody was kindly provided by BMA Biomedicals (Augst,
Switzerland). PE±streptavidin, TriColor±streptavidin and PE±
goat anti-rat IgG (mouse absorbed) were used as conjugates
(Caltag, San Francisco, CA).
Cell suspensions
Single-cell suspensions of BM, isolated from femora and
tibiae, were prepared as described previously (20,21).
Similarly, single-cell suspensions of spleen and lymph nodes
were prepared and used for T cell isolation as described (22).
Cultured BM-derived DC were isolated from Te¯on culture
bags or from culture plates. Cells were washed in PBS
supplemented with 5% FCS (heat inactivated), 60 mg/ml
penicillin and 100 mg/ml streptomycin when sterile suspen-
sions were required. Prior to phenotypic analysis, cultured
cells were washed with PBS supplemented with 0.5% (v/v)
BSA (Organon Teknika, Boxtel, The Netherlands) and 20 mM
sodium azide.
Cell sorting and ¯ow cytometric analysis
For cell sorting, BM cells were labeled with two (ER-MP12 and
ER-MP20) or three (ER-MP12, ER-MP20, and ER-MP58) mAb
as described previously (20,21). Prior to sorting (FACS
Vantage; Becton Dickinson, Amsterdam, The Netherlands),
cell suspensions were ®ltered over a 30-mm sieve (Polymon
PES; Kabel, Amsterdam, The Netherlands) to avoid clogging
of the nozzle. After sorting, the purity of the cell suspensions
was checked by re-running sorted samples. Purity was >95%,
unless stated otherwise. Suspensions were kept at 4°C
throughout the staining and sorting procedure. Sorted cells
were counted in a BuÈrker hemocytometer.
For ¯ow cytometric analysis, samples of cultured cells (>2
3 104 cells) were aliquoted into 96-microwell plates (round
bottom; Nunc, Roskilde, Denmark) and labeled with anti-
bodies as described before (21). Samples were analyzed on a
FACSCalibur ¯ow cytometer using CellQuest analysis soft-
ware (Becton Dickinson).
Immunocytochemistry on poly-L-lysine-coated slides
For immunocytochemical analysis, aliquots of cultured cells
were placed at 37°C, 7% CO2 in complete medium for 1 h to
adhere to poly-L-lysine-coated microwell slides (Nutacon,
Schiphol-Oost, The Netherlands). Next, cell preparations
were gently washed once with PBS (37°C), ®xed in 1%
paraformaldehyde in PBS for 10 min at room temperature, and
washed with PBS and with PBS supplemented with 0.5% BSA.
Cells were incubated with primary mAb, followed by rabbit
anti-rat IgG conjugated to horseradish peroxidase (HRP;
Jackson ImmunoResearch, West Grove, PA) (both incuba-
tions 30 min at room temperature). Diaminobenzidine (DAB;
Sigma, St Louis, MO) was used as substrate. Between
incubations, cell preparations were washed in PBS supple-
mented with 0.5% (v/v) Tween 20. After the DAB reaction was
completed (3±5 min at room temperature), the cell prepar-
ations were dehydrated and coverslipped using Entallan
(Merck, Darmstadt, Germany). Antibody reactivity was deter-
mined under a light microscope. Culture supernatant of the Y3
myeloma followed by the second stage antibody was used as
negative control.
Growth factors
Conditioned medium of LADMAC cells was used as a source
of mouse macrophage colony stimulating factor (M-CSF) (23).
Conditioned medium was prepared as described else-
where (19). Recombinant mouse GM-CSF (rGM-CSF) was
purchased from Biosource International (Camarillo, CA).
rGM-CSF- and M-CSF-stimulated BM cultures
DC were generated by culturing total BM or isolated subsets in
Te¯on culture bags (24) or 24 well plates (Nunc) in RPMI-1640
(no HEPES; Biowhittaker, Verviers, Belgium) supplemented
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with 10% FCS (heat inactivated; 0.2 mm ®ltered), 60 mg/ml
penicillin, 100 mg/ml streptomycin and 20 ng/ml rGM-CSF.
Cells were cultured at 37°C, 7% CO2 for various periods of
time, as indicated, for up to 14 days. Differentiation of isolated
BM subsets, to macrophages, was induced by culturing in
Te¯on culture bags (24) in IMDM (with glutamax I; Gibco,
Invitrogen BV, Breda, The Netherlands) supplemented with
20% FCS (heat inactivated; 0.2 mm ®ltered), 15% LADMAC-
conditioned medium as a source of M-CSF, 100 mM
2-mercaptoethanol, 60 mg/ml penicillin and 100 mg/ml strepto-
mycin. Cells were cultured for 4 or 5 days at 37°C, 7% CO2 as
indicated.
MLR
In vitro generated DC (stimulator cells) and T cells (responder
cells) isolated from the spleen and lymph nodes were
resuspended in RPMI 1640 supplemented with 25 mM
HEPES, 10% FCS (heat inactivated; 0.2 mm ®ltered), 60 mg/
ml penicillin, 100 mg/ml streptomycin, 20 mg/l sodium pyruvate
and 50 mM 2-mercaptoethanol (further referred to as MLR
medium). T cells were resuspended at a concentration of 2 3
106/ml and the concentration of DC varied depending on the
desired ratio of DC:T cells. The cells (100 ml of each cell
suspension) were incubated in round-bottom 96-well plates for
4 days at 37°C, 7% CO2. DC and T cells, incubated separately
in MLR medium, were used as negative controls. Mitogenic
stimulation of T cells by concanavalin A (®nal concentration
1.25 mg/ml) (Sigma) was used as a positive control.
After 4 days of co-culture, cells were harvested and
analyzed by ¯ow cytometry. Triple labeling of cells with anti-
CD4, anti-CD8 and ER-MP21 antibodies was performed, and
15,000 events within the living gate was acquired. Analysis
was performed using CellQuest analysis software. The per-
centage of ER-MP21 (CD71/transferrin R)+ cells, as a measure
of proliferating cells, was determined within the CD4+ and
CD8+ population. This method of analysis provides compar-
able results to those obtained with the [3H]thymidine incorp-
oration method (unpublished results) and in addition allows us
to analyze, in more detail, the characteristics of the respond-
ing T cell population
Results
Distinct DC precursors in the BM can be identi®ed by
ER-MP12/20 labeling
Based on ER-MP12/CD31 and ER-MP20/Ly-6C expression,
we can fractionate BM into six separate, morphologically and
phenotypically distinct subsets (Fig. 1) as we showed previ-
ously (25,26). We also demonstrated that in this way the
different hematopoietic lineages (lymphoid, erythroid, granu-
locytic and monocytic) and three different stages of macro-
phage precursors could be distinguished (21,26). To examine
in which of the cell populations DC precursors were present,
BM subsets were sorted and cultured with GM-CSF. At day 10
of culture, the development of DC was evaluated by examining
the cultures under an inverted light microscope (Table 1). DC
were clearly visible in cultures derived from ER-MP12hi20±, ER-
MP12+20+ and ER-MP12±20hi subsets. No DC or other cell
Fig. 1. Flow cytometric dot-plot of ER-MP12/20-labeled BM cells.
Upon double labeling of BM cells with these mAb, six distinct
subsets can be discerned. Gates used for cell sorting are shown.
Percentages are the mean of ®ve experiments.
Table 1. DC-like cells generated from ER-MP12/20 bone marrow subsets
BM subset Overall cell
growtha
DC-like cells visible in cultureb MHC class II++ cells with DC morphology
(immunocytochemistry) (%)
Day 6 Day 10 Day 6 Day 10
Exp. I Exp. II Exp. I Exp. II
ER-MP12hi20± + 6 + 6 ND 15 9
ER-MP12med20± ± ± ± ± ± ± ±
ER-MP12±20± ± ± ± ± ± ± ±
ER-MP12+20+ + + + 20 43 16 ND
ER-MP12±20med ± ± ± ± ± ± ±
ER-MP12±20hi + + + 23 26 40 33
TBM + + + 19 ND 23 ND
aDuring entire culture.
bResults are for Experiments I and II as they were identical.
ND, not enough cells present on the poly-L-lysine-coated slides to determine percentage MHC class II+ cells.
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types could be grown from the ER-MP12med20±, ER-MP12±20±
and ER-MP12±20med subsets by GM-CSF stimulation. The
latter BM subsets consisted of morphologically identi®able
cells of the lymphoid, erythroid and granulocytic lineage
respectively (21,26).
The presence of DC in cultures was also examined by
assessing MHC class II expression in immunocytochemistry
(Fig. 2). DC derived from different precursor populations
showed the same typical DC morphology with MHC class II
molecules present preferentially on the cell surface. However,
the frequency of MHC class IIhi DC at day 6 (Table 1) in the ER-
MP12hi20± culture was lower than that in the ER-MP12+20+ and
ER-MP12±20hi cultures (an average of 6 versus 33 and 25%
respectively), suggesting that precursors from the ER-
MP12hi20± population needed more time to develop into DC.
This was in agreement with the results from visual examination
of the cultures. By day 10, the frequency of DC had increased
in the cultures derived from the ER-MP12hi20± subset (on
average 12%), but was still lower than that in the ER-MP12+20+
(16%) and ER-MP12±20hi (on average 37%) subsets. In
conclusion, on the basis of differential ER-MP12 and ER-
MP20 expression, we can distinguish three subsets in mouse
BM from which DC can be derived with GM-CSF.
DC derived from different ER-MP12/20 populations develop
into fully mature cells
Immature and mature DC differ in the level of MHC class II
molecule expression on their surface. To determine the
maturation state of DC derived with GM-CSF from different
BM subpopulations, we double-stained cells at the end of
culture with CD11c and anti-MHC class II antibodies. On the
gated CD11c+ population, we measured the expression of
MHC class II molecules (Fig. 3A): 30, 76, 76 and 91%
CD11c+MHC class IIhi mature DC were present in cultures
derived from ER-MP12hi20±, ER-MP12+20+, ER-MP12±20hi and
TBM respectively. In addition, all cultures contained a
relatively low percentage of CD11c+MHC class IIlo immature
DC, except for the culture derived from the ER-MP12hi20± DC
precursors in which a signi®cant amount of DC was still
immature (50%). These immature cells responded very well to
overnight lipopolysaccharide (LPS) stimulation as this induced
a signi®cant increase of the percentage of mature
CD11c+MHC class IIhi cells (Fig. 3B). All cultures contained
also some CD11c±MHC class II± cells (not shown), which are
mainly granulocytes also developing in vitro with GM-CSF.
To investigate the functionality of DC derived from different
precursor subpopulations, we assessed their antigen-pre-
senting capacity by co-culturing GM-CSF derived cells with
puri®ed T cells (Fig. 3C). DC derived from all three BM
subpopulations were good activators of T cells. The MLR
stimulatory capacity was enhanced after LPS stimulation,
particularly in the culture derived from the ER-MP12hi20±
subpopulation when tested at lower DC:T cell ratios.
Three ER-MP12/20-de®ned subpopulations represent
successive maturation stages of DC precursors in the BM
Morphological and functional analysis of DC cultures showed
that different BM subpopulations develop with different
kinetics into similar DC, which suggests that precursors in
these populations might be in a different maturation stage at
the time of isolation. To investigate this, we sorted the ER-
MP12hi20±, ER-MP12+20+ and ER-MP12±20hi subpopulations
from the BM, stimulated them with GM-CSF in vitro, and
analyzed the expression of ER-MP12 and ER-MP20 by
cultured cells at various time points (Fig. 4).
At day 2 of culture, cells from the ER-MP12hi20± subpopula-
tion had up-regulated ER-MP20 on their surface and about a
half of them were double positive for both markers. By day 5 all
cells derived from this population were ER-MP20+ while most
of them showed no ER-MP12 expression anymore. By day 8,
the culture contained ER-MP12/20 double-negative cells and
those that expressed medium levels of ER-MP20. The ER-
MP12+20+ population followed a similar pathway of develop-
ment. At day 2, most of the cells had down-regulated ER-MP12
Fig. 2. Immunocytochemical MHC class II staining on cells from day 6 GM-CSF-stimulated cultures. DC (identi®ed as MHC class IIhi and
typical dendritic morphology) from cultures grown from (A) ER-MP12hi20±, (B) ER-MP12+20+ and (C) ER-MP12±20hi BM cells are shown.
Macrophages were also present in the cultures (arrow) and differed from DC in morphology and MHC class II expression (lower levels).
Original magni®cation 3590.
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expression and were ER-MP12±20+. At day 5 of culture, some
cells also down-regulated ER-MP20 and were double nega-
tive. By day 8 almost all cells had lost both markers on their
surface and were ER-MP12±20±. Finally, the ER-MP12±20hi -
derived cells also down-regulated ER-MP20 on majority of the
cells by day 5 of culture. By day 8 most of the cells in this
culture had died (they probably were fully differentiated
already before day 8) so no phenotypical analysis could be
performed at this time point. Importantly, in all investigated
cultures cells successively pass through the ER-MP12+20+
and ER-MP12±20hi stages and ®nally become ER-MP12±20±.
In the same cultures we followed the development of DC by
using the DC marker CD11c. A common pattern of in vitro DC
development was observed in cultures from all three fractions:
®rst CD11c expression was induced followed by a prompt
down-regulation of ER-MP20 (Fig. 5). CD11c+ cells were
present already at day 2 in the culture derived from the ER-
MP12±20hi subpopulation. CD11c+ cells were also present at
day 2 in cultures derived from the ER-MP12+20+ subpopula-
tion, but at much lower frequency. The percentage of CD11c+
cells was increased in both cultures at day 5 and continued to
rise in cultures derived from the ER-MP12+20+ subpopulation
to reach 91% at day 8 of culture. In contrast, in cultures
derived from the ER-MP12hi20± precursors, CD11c+ cells were
present only from day 5 (10%) and reached 45% at day 8 of
culture, implying that these precursors are indeed the earliest
precursors able to differentiate into DC when stimulated with
GM-CSF.
The maturation sequence of BM DC precursors, indicated
by these phenotypic studies, is consistent with the decreasing
proliferative capacity of the cells with increasing maturity. GM-
CSF-stimulated culture of the distinct subsets in semi-solid
medium demonstrated that the ER-MP12hi20± subset gener-
ated predominantly large colonies (>50 cells), the ER-
MP12+20+ subset predominantly clusters (<50 cells) and
some smaller colonies, while the ER-MP12±20hi subset gave
rise primarily to small clusters. Liquid culture recoveries were
in line with these ®ndings. In a representative experiment, 1 3
105 cells from the ER-MP12hi20± population produced 4 3 106
cells after 7 days of culture, thus multiplying their starting
number 40 times. From 4 3 105 ER-MP12+20+ cells, 3.6 3 106
progeny cells (9-fold) were generated, while 4 3 105 ER-
MP12±20hi cells gave rise to only 2.8 3 105 cells after culture
(0.7-fold).
The earliest ER-MP12hi20± DC precursors have the
phenotype of myeloid-committed cells
Previously, we showed that the same ER-MP12/20-de®ned
subpopulations in the BM contain macrophage precursors as
we found now for DC precursors (21). In addition, we also
showed that within the ER-MP12hi20± subpopulation, early
myeloid-committed cells could be puri®ed from the other
hematopoietic differentiation capacities on the basis of differ-
ential expression of a third marker, ER-MP58 (20). Since we
found that DC could also be generated from the ER-MP12hi20±
BM subset, we asked whether the earliest DC precursors also
have a myeloid-committed phenotype by examining their ER-
MP58 expression. For this purpose, ER-MP12hi20± BM cells
were fractionated according to their level of ER-MP58 expres-
sion (Fig. 6) and cultured in the presence of GM-CSF. Cultures
were examined microscopically for the presence of DC at
different time points. Starting from day 7 (Table 2), morpho-
logically mature DC could only be detected in cultures of the
ER-MP58hi subset within the ER-MP12hi20± population. This
onset of DC appearing in culture was similar to what was
observed when the total ER-MP12hi20± subset was cultured
(see above). No DC-like cells could be grown from the ER-
MP58med and ER-MP58±/lo subsets under these culture condi-
tions. Together, these data show that, like macrophage
precursors, GM-CSF-responsive DC precursors present in
the ER-MP12hi20± BM subset are characterized by a high level
Fig. 3. Flow cytometric and functional analysis of DC generated from BM precursors. (A) Cells derived from the total BM and three different
precursor populations are double stained with MHC class II and CD11c antibodies. Histograms show the MHC class II expression by CD11c+-
gated cells. (B) DC derived from the ER-MP12hi20± population matured upon 24 h LPS stimulation as measured by enhancement of MHC
class II expression. The pro®le indicated by a solid line only represents the expression before LPS stimulation; the ®lled surface is after 24 h
LPS stimulation. The dotted line marks the isotype control and numbers represent the percentage of MHC class IIhi cells. (C) Potential of DC,
either or not treated with LPS, derived from different BM precursors to stimulate T cells in the MLR. T cell activation is measured by expression
of transferrin R (ER-MP21) on their surface.
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of ER-MP58 expression and thus have a myeloid-committed
phenotype.
BM progenitors maturing along the macrophage lineage
in vitro maintain the capacity to generate DC
To approach the question whether macrophages and DC
share progenitors throughout their BM development, we
cultured BM subsets sequentially with M-CSF (`primary
culture') and GM-CSF (`secondary culture'). ER-MP12hi20±
58hi (early myeloid precursors) and ER-MP12+20+ (myeloid
blasts) were induced ®rst to develop along the macrophage
lineage in vitro (21). M-CSF was then replaced by GM-CSF
and the potential of macrophage precursors to form DC was
measured.
After 4 days in M-CSF-stimulated culture of the ER-
MP12hi20±58hi subset, ~90% of the cultured cells expressed
the ER-MP20 antigen at a high level (Fig. 7A), representing BM
monocytes as previously shown (21). Changing the growth
stimulus to GM-CSF at this point resulted in the appearance of
DC only 1 day later as determined by morphological inspec-
tion. The more mature ER-MP12+20+ subset developed further
along the macrophage pathway in vitro, since after 5 days of
M-CSF-stimulated culture approximately half of the cells still
expressed the ER-MP20 antigen, whereas the other cells in the
culture had lost their ER-MP20 expression (Fig. 7B). When
these cells were further stimulated by GM-CSF, similarly to
ER-MP12hi20±58hi-derived cultures, DC were visible after only
1 day of secondary culture and in increased numbers after
3 days of culture. Apart from DC, macrophages (ER-MP20±)
also developed in cultures from both precursor fractions as
indicated by the presence of cells with (i) high forward and
perpendicular light scatter (data not shown), indicative of a
complex cell type like the mature macrophage with its
numerous vacuoles, etc., and (ii) a high auto¯uorescence
level, also characteristic of mature macrophages. After 9 days
of GM-CSF-stimulated secondary culture, 28 and 71% DC
developed from ER-MP12hi20±58hi and ER-MP12+20+ derived
cultures respectively. These cells expressed MHC class II
molecules at a high level and had typical DC morphology, as
determined in immunocytochemistry (Fig. 7C and D). Thus,
myeloid precursors from the BM developing for 4 or 5 days
along the macrophage lineage in M-CSF-stimulated culture
still have the potential to generate DC.
Discussion
In the past few years a signi®cant amount of data has been
generated about different DC types and their relationship to
other hematopoietic lineages. Recently, it has been shown that
both common myeloid and common lymphoid precursors can
give rise to different DC types both in vitro and in vivo (14±16).
Mature myeloid and lymphoid DC have been identi®ed
Fig. 4. Successive expression of ER-MP12 and ER-MP20 during the in vitro culture of BM precursor populations. Sorted populations were
cultured with GM-CSF, and at various time points double-labeled with ER-MP12 and ER-MP20. Starting from the earliest precursor population,
ER-MP12hi20±, all cells show the same pattern of ER-MP12/20 expression, indicating that they follow the same ER-MP12hi20± ® ER-MP12+20+
® ER-MP12±20hi developmental pathway.
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phenotypically in human and also in mouse (3,4). However, the
exact maturation pathways of either of the types have
remained unclear.
In this study we have examined the different stages of BM
DC precursor development in vivo, as de®ned by the expres-
sion of ER-MP12/CD31, ER-MP20/Ly-6C and ER-MP58 anti-
gens. DC are derived in vitro with GM-CSF only from the ER-
MP12hi20± (early blasts), ER-MP12+20+ (myeloid blasts) and
ER-MP12±20hi (BM monocytes) (21) subpopulations, while no
cell growth could be detected from the other three sorted
populations, ER-MP12med20±, ER-MP12±20± and ER-MP12±
20med. These populations represent subsets containing
morphologically identi®able precursors and mature cells of
the other hematopoietic lineages (lymphoid, erythroid and
granulocytic respectively). Our results show that GM-CSF-
responsive DC precursors reside in the same ER-MP12/20-
de®ned BM subsets as M-CSF-responsive macrophage pre-
cursors (19±21).
Earlier reports show that mature DC develop from the BM
within 8 days in GM-CSF-stimulated culture (27). In agreement
with this we observe that the majority of DC derived from any of
the BM subpopulations express signi®cant amounts of MHC
class II molecules, which, together with their good potential to
stimulate allogeneic naive T cells in vitro, indicates that mature
Fig. 5. Kinetics of the in vitro DC development from different BM precursors. Subpopulations were sorted from the BM and cultured for 8 days
in the presence of GM-CSF. At different time points cells were labeled with ER-MP20 and CD11c. The DC development is marked by up-
regulation of CD11c on the cell surface.
Table 2. DC generated from ER-MP12hi20± bone marrow
subsets
BM subset Overall cell growtha DC visible in culture
Day 5 Day 7 Day 14
ER-MP12hi20±58hi + ± + +
ER-MP12hi20±58med/lo 6 ± ± ±
ER-MP12hi20±58±/lo ± ± ± ±
aDuring entire culture.
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DC develop in these cultures. However, in cultures derived
from the ER-MP12hi20± cells, immature DC, expressing
medium levels of MHC class II, were also present in signi®cant
numbers after 7 days of culture. These cells mature upon LPS
stimulation, suggesting that they need an extended period of
time to develop into mature DC since they develop from early
precursors.
This delay in reaching a mature state is in agreement with
the observation that during the in vitro development, a
difference in time of appearance of CD11c+ cells exists in
cultures grown from the ER-MP12hi20± versus the ER-
MP12+20+ and ER-MP12±20hi BM subsets (day 5 versus 2
respectively). This further implies that ER-MP12hi20± DC
precursors are less mature than the other two subsets, and
need more time to develop into DC than ER-MP12+20+ and
ER-MP12±20hi cells. In addition, the percentage of CD11c+ DC
derived from the GM-CSF-stimulated ER-MP12+20+ cells is 2-
fold higher than that found with the ER-MP12hi20± BM subset
as a starting population (90 versus 45%). Probably the higher
proliferative capacity of the ER-MP12hi20± population contrib-
utes to the observed difference in maturation kinetics. Both the
size and extent of colony/cluster formation and culture
recoveries indicate that ER-MP12hi20± cells have the highest
potential to proliferate, which then decreases to be the lowest
among ER-MP12±20hi cells. The high recoveries obtained from
the ER-MP12hi20± and ER-MP12+20+ fractions make it highly
unlikely that contaminating populations (<5%) in the sorted
fractions account for the observed results. Together, these
®ndings reinforce the notion that ER-MP12hi20±, ER-MP12+20+
and ER-MP12±20hi populations represent different stages of
DC development, since they show a reciprocal relationship
between the ability to proliferate and the ability to develop into
mature DC in a short period of time.
The successive expression of ER-MP12 and ER-MP20
antigens during the in vitro culture with GM-CSF strongly
suggests that the three DC precursor populations, which we
de®ned in the BM, differentiate along the pathway with the
order ER-MP12hi20± ® ER-MP12+20+ ® ER-MP12±20hi.
Furthermore, this same sequence was previously shown for
the macrophage precursors (21) suggesting that GM-CSF-
responsive myeloid DC and macrophage precursors follow a
similar ER-MP12/20-de®ned developmental pathway.
The population that contains the earliest DC precursors in
the BM, ER-MP12hi20±, can be further divided into three
subpopulations based on the expression of the early myeloid
marker ER-MP58 (20). Of these three subsets, only ER-
MP12hi20±58hi BM cells are able to differentiate into DC in rGM-
CSF-stimulated cultures. Since high level expression of ER-
MP58 within the ER-MP12hi20± BM population has been shown
to mark the earliest myeloid committed precursors, able to
give rise to macrophages with M-CSF (20), we conclude that
macrophages and myeloid DC most probably originate from
the same precursors in the BM. Recently, Akashi et al. have
described the existence of a common myeloid progenitor in
mouse BM that gives rise to all myeloid lineages (10). The
comparison of its colony forming ability and further charac-
teristics with those of the ER-MP12hi20±58hi population strongly
suggests that the latter represents a similar, if not identical,
multipotent myeloid precursor population.
In a recently published paper (7), Gilliet et al. show that the
mouse PDC (CD11c+CD11b±B220+) can be generated in vitro
from the total BM, when Flt-3L is used as the growth factor.
They also show that addition of GM-CSF to the culture medium
completely blocks generation of PDC and increases myeloid
DC development. Since we used GM-CSF alone, this is in
agreement with the observation that in our cultures, no
plasmacytoid, but only myeloid DC, were generated as all
cells in the culture expressed high levels of CD11b (data not
shown). An interesting question arises regarding the potential
of our three populations to generate PDC with Flt-3L. For the
BM monocyte population (ER-MP12±20hi) we regard it unlikely
that they may give rise to lymphoid-related PDC, as we have
shown previously that BM monocytes are all CD11b+ and thus
myeloid cells (21), Further, it has been reported that the
CD31+/Ly-6C+ (i.e. our ER-MP12+20+) population contains
precursor cells capable of differentiating into different cell
types: CD8a+ DC, CD8a± DC, PDC and macrophages,
depending on the experimental conditions (17). Our current
results support the concept that developing myeloid DC,
which might eventually express CD8a, and macrophages
progress through the same precursor stages in the BM
Fig. 6. ER-MP58 expression within the ER-MP12hi20± gate. Cells
were triple labeled with ER-MP12, ER-MP20 and ER-MP58. ER-
MP12hi20± cells were gated (A) and sorted on the basis of their ER-
MP58 expression as indicated (B).
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including the CD31+/Ly-6C+ stage. However, as we have
shown earlier, the CD31+Ly-6C+ population in BM is pheno-
typically heterogeneous (21) and might contain cells with
different developmental capabilities; clonal assays are essen-
tial to prove whether PDC and myeloid DC derive from single
precursors. Finally, we de®ne the DC precursor, at the stage
prior to the one previously reported, which is capable of
differentiating in both myeloid DC and macrophages (CD31hi/
Ly-6C±). As mentioned above, since GM-CSF directs cell
development speci®cally to myeloid lineage, it is unclear from
our data whether PDC might originate from the same popu-
lation.
Taken together, in this report, we de®ne different stages of
GM-CSF-responsive DC precursors present in the BM and
show their in vivo developmental pathway. Furthermore, we
show that, throughout their BM development, myeloid DC
precursors progress through the same stages as macro-
phages. Even when cells are induced in vitro with M-CSF to
follow the macrophage developmental pathway, they can still
be redirected to develop into DC when M-CSF is replaced
with GM-CSF. This is in line with our hypothesis that over
a prolonged stretch of development, progenitors of the
mononuclear phagocyte system may either develop into
macrophages or DC, depending on local conditions.
However, additional clonal experiments are required to con-
®rm this hypothesis. Finally, we feel that the ER-MP12/20/58
identi®cation of distinct BM subsets provides a powerful
means to study the developmental pathway of lymphoid-
related PDC as opposed to the presently studied myeloid DC.
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